<DOC>
	<DOCNO>NCT02674048</DOCNO>
	<brief_summary>Prospective non-interventional study conduct Australia , Brazil , Mexico Europe evaluate clinical practice Metvix Daylight PDT treatment mild moderate actinic keratosis face/scalp ass physician patient satisfaction .</brief_summary>
	<brief_title>Metvix Daylight PDT Actinic Keratosis</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<criteria>Patients MetvixÂ® DaylightPDT already prescribe physician , accord local label ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>